the potential of her2-, her3-, and trop2-targeted therapies to address unmet needs in advanced nsclc
Published 3 years ago • 997 plays • Length 58:30
Download video MP4
Download video MP3
Similar videos
-
58:27
addressing key targets in advanced nsclc: her2-, her3-, and trop2-targeted therapies
-
25:26
locally advanced nsclc: combination therapy with targeted and immunotherapy agents
-
0:37
targeted therapy | cancer treatment | molecular approach | we cure fear first
-
14:45
potential and progress in targeting less common markers: her2, braf, kras, met, trk, and ret
-
30:41
small cell lung cancer treatment advancements: unlocking hope through breakthrough therapies
-
20:34
2021 west oncology | lung cancer | egfr mutation therapy resistance and adcs and trop2
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
56:23
are you prepared for the new wave of adcs in nsclc? targeting her2, her3, trop2, and others
-
8:04
unlocking the secrets of small cell lung cancer: what you need to know now!
-
3:14
advancements of targeted therapy for egfr mutations in nsclc
-
33:52
keynote lecture: targeted therapies in lung cancer 2.0 – advances and promises
-
0:32
potential targeted therapy for lung cancer
-
3:02
the future of ret nsclc treatment - targeted therapies in lung cancer 2023
-
31:51
lung cancer breakout: breakthrough treatments for longer life
-
49:56
reshaping the future of lung cancer treatment with trop2-targeting adcs and rational combinations
-
0:34
targeted therapy: a better approach to cancer treatment? i mrmed
-
1:22
recent advances in targeted agents for the treatment of lung cancer
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
0:48
adriatic study: new standard of care treatment for small cell lung cancer
Clip.africa.com - Privacy-policy